bearish
Aier Eye Hospital Group (300015.CH) - More than Just Bribery Scandal
378 Views20 Jan 2022 09:11
The recent bribery scandal of Aier has raised widespread concern,but may not fundamentally overturn Aier.The biggest risk is the revolutionary technology/drugs to form a "dimensional reduction attack"
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 3-minute read)
Discussions
(Paid Plans Only)
Top 5%
Xinyao (Criss) Wang
HK/China Healthcare Analyst (ex-Fosun Pharma)
Price Chart(Sign Up to Access)
- Aier Eye Hospital Group (300015.CH) 2021/2022Q1 Results - Overvaluation and a Risky Outlook18 May 2022
- Hygeia Healthcare Group (6078.HK) 2021 Results - Solid Business Logic Comes with Policy Risk20 Apr 2022
- Pre IPO Ascent ENT Group Holdings - Conservative About the Outlook10 Mar 2022
- The Insecure Rebound in Healthcare Sector and the Future Direction of Stock Price (2022)17 Jan 2022
- Aier Eye Hospital Group (300015.CH) - The Concerns Behind the High Growth Momentum28 Sep 2021
- Aier Eye Hospital(300015.CH) - The Largest Ophthalmic Chain in China with Promising Growth Potential09 Dec 2020
x